Segall Bryant & Hamill LLC Sells 5,315 Shares of Novanta Inc. $NOVT

Segall Bryant & Hamill LLC trimmed its holdings in shares of Novanta Inc. (NASDAQ:NOVT) by 4.9% during the 1st quarter, HoldingsChannel reports. The institutional investor owned 103,033 shares of the technology company’s stock after selling 5,315 shares during the period. Segall Bryant & Hamill LLC’s holdings in Novanta were worth $12,169,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of NOVT. Argent Capital Management LLC increased its holdings in shares of Novanta by 55.4% during the 1st quarter. Argent Capital Management LLC now owns 7,670 shares of the technology company’s stock valued at $906,000 after acquiring an additional 2,735 shares during the last quarter. Bank of America Corp DE lifted its holdings in Novanta by 18.3% in the 1st quarter. Bank of America Corp DE now owns 456,241 shares of the technology company’s stock worth $53,887,000 after purchasing an additional 70,728 shares during the last quarter. Amundi boosted its position in Novanta by 17.9% during the first quarter. Amundi now owns 23,187 shares of the technology company’s stock worth $2,739,000 after purchasing an additional 3,516 shares during the period. California State Teachers Retirement System grew its holdings in Novanta by 22.0% during the first quarter. California State Teachers Retirement System now owns 41,627 shares of the technology company’s stock valued at $4,917,000 after purchasing an additional 7,506 shares during the last quarter. Finally, Quantinno Capital Management LP grew its holdings in Novanta by 1.6% during the first quarter. Quantinno Capital Management LP now owns 10,746 shares of the technology company’s stock valued at $1,269,000 after purchasing an additional 169 shares during the last quarter. 98.35% of the stock is currently owned by institutional investors.

Insider Activity

In other news, CEO Matthijs Glastra sold 6,500 shares of the firm’s stock in a transaction on Thursday, July 2nd. The shares were sold at an average price of $161.13, for a total value of $1,047,345.00. Following the sale, the chief executive officer owned 29,761 shares in the company, valued at approximately $4,795,389.93. This trade represents a 17.93% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 1.20% of the company’s stock.

Novanta Price Performance

Shares of NASDAQ:NOVT opened at $142.55 on Monday. The business has a 50 day moving average price of $154.33 and a 200 day moving average price of $140.76. Novanta Inc. has a twelve month low of $98.27 and a twelve month high of $171.85. The company has a market cap of $5.38 billion, a price-to-earnings ratio of 103.30 and a beta of 1.68. The company has a quick ratio of 2.69, a current ratio of 3.56 and a debt-to-equity ratio of 0.15.

Novanta (NASDAQ:NOVT) last issued its quarterly earnings results on Monday, May 11th. The technology company reported $0.81 EPS for the quarter, topping the consensus estimate of $0.78 by $0.03. Novanta had a return on equity of 12.06% and a net margin of 5.35%.The company had revenue of $257.71 million for the quarter, compared to the consensus estimate of $253.40 million. During the same period in the previous year, the business posted $0.74 EPS. The company’s revenue for the quarter was up 10.4% on a year-over-year basis. Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q2 2026 guidance at 0.810-0.860 EPS. Research analysts predict that Novanta Inc. will post 3.59 earnings per share for the current year.

Analyst Ratings Changes

A number of analysts have recently weighed in on NOVT shares. Wall Street Zen cut shares of Novanta from a “buy” rating to a “hold” rating in a research note on Saturday. Robert W. Baird set a $180.00 target price on shares of Novanta in a research note on Tuesday, June 9th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Novanta in a report on Wednesday, July 15th. One research analyst has rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $180.00.

About Novanta

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.